Study of Magrolimab in Patients With Solid Tumors

NCT04827576 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

106

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision to terminate study

Conditions

Solid Tumor

Interventions

DRUG: Magrolimab
DRUG: Docetaxel

Sponsor

Gilead Sciences